Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

In another China pact, Lilly makes a deal with InnoCare worth up to $3.35B

Eli Lilly has signed up Beijing-based InnoCare to develop new medicines in a partnership that could be worth up to $3.35 billion if the products go on sale. InnoCare will use its in-house drug discovery ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 24 September →